NDC 16571-657
Cevimeline Hydrochloride
Cevimeline Hydrochloride
Cevimeline Hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is Cevimeline Hydrochloride.
| Product ID | 16571-657_75781c14-f302-4751-843e-5832c25c9538 |
| NDC | 16571-657 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cevimeline Hydrochloride |
| Generic Name | Cevimeline Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-06-17 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203775 |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | CEVIMELINE HYDROCHLORIDE |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |